| Micro-channel |
 |
|
|
|
|
|
| |
| It is the reporter who investigates the price of the drug that rises 20 times the price of the drug |
| |
| Author：中國(guó)銘鉉 企劃部 Release Time：2017-8-10 8:49:47 Number Browse：632 |
| |
The medical website on August 9, the reporter investigated the usual drugs, the price has skyrocketed 20 times!
▍ reporter investigation: 20 times have drug prices
On August 8, cnr.cn reported that the reporter had investigated the price of the normal drug in jinan, and the eye cream of erythromycin was one of the first few cents, and went up to four sixes.
Not only that, but the price of a bottle of glutamin, which used to be six cents a bottle, is now up to 8.5 yuan a bottle. A box of seven yuan for lipitor, a coronary heart disease, now costs more than 60 yuan per box. The price of the high-tri-picolinine injection, which is used to treat acute undribbub leukemia, has risen from $5 a year ago to $110 now, and the price has soared more than 20 times.
In addition, according to industry feedback, each bottle of isoniazid is 4 yuan, which is up to 82 yuan. There are many examples of propranolol hydrochloride tablets rising from 0.8 yuan per bottle to 15 yuan a year for more than a year. In addition to the normal market price, price inflation, it seems that the target is the monopoly of API!
▍ API monopoly is the culprit, the illegal cost is too low
Ma manager of a shandong pharmaceutical company said the price rise of cheap drugs does not rule out some pharmaceutical companies pushing up the price of drugs by monopolizing their position, cnr.cn reported.
"For a period of time before such as more heat of protamine, may be only two production, is one of the manufacturers in Beijing in the north, the south is the enterprise production in Shanghai, they unite to corner the market, put pressure on the government and society to raise prices, this kind of phenomenon also is some."
In addition, it is widely reflected in the industry, and currently the illegal cost is too low.
On August 1, in the blue parker, issued the illegal monopoly raw material, the two drug firms were punished by "the national development and reform commission (two drug firms monopoly was fined 400000), after reports of many industry players expressed similar views: fines is too little, not a dangerous tiger effect.
▍ hundreds of active pharmaceutical ingredients or monopoly
Since 2011, the national price departments have dealt with promethazine hydrochloride, don't Piao alcohol, estazolam, isoniazid and other several drugs and drug substances to enter on the implementation of price monopoly, but since then, and chlortetracycline hydrochloride, erythromycin, don't Piao alcohol, calamine and ranitidine hydrochloride and diclofenac sodium API was the news of a monopoly.
Hence, there is even a view that hundreds of apis all over the country have been monopolized.
▍ besides hitting, there is no it
Released on June 28, nine ministries and commissions on the reform to perfect the shortage of drug supply security mechanism of the implementation opinions ", said to the price rise obvious active pharmaceutical ingredients and drug production and circulation enterprises, when it is necessary to carry out special investigation cost price. More recently, there will be a targeted document.
According to the economic information daily, a guide to the price behavior of the drug monopoly API will be consulted in the near future. Experts say that the introduction of the document will curb illegal price rises, malicious control and other behaviors, and it is of great significance for stabilizing drug prices and cooperating with health reform.
However, there is the industry that rely on a guide significance to the file, it is also hard to completely change the present shortage drug pricing environment, "only to crack down on monopolies, the most effective!" |
| |
Previous article：Anhui province also wants to ban bribing companies in public hospital procurement
Next article：Anhui province: the drug agent for the record, to sign a clean contract!
|
| |
|
|
